Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.81 |
| ▸ | POLB | P06746 | 4/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.63 |
| ▸ | GAA | P10253 | 3/20 | 0.63 |
| ▸ | HPGD | P15428 | 3/20 | 0.63 |
| ▸ | CASP1 | P29466 | 3/20 | 0.63 |
| ▸ | CASP7 | P55210 | 3/20 | 0.63 |
| ▸ | GLA | P06280 | 2/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 4/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.58 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxazorone SCHEMBL2109280 | 0.84 | TDP1 (0.66) | TDP1POLBKDM4EHSD17B10KMT2A | |
| Oxazorone SCHEMBL29913823 | 0.84 | TDP1 (0.66) | TDP1POLBKDM4EHSD17B10KMT2A | |
| SCHEMBL8708592 | 0.80 | KMT2A (0.64) | TDP1POLBKDM4EHSD17B10KMT2A | |
| SCHEMBL30507291 | 0.79 | ALDH1A1 (0.70) | TDP1POLBKDM4EHSD17B10KMT2A | |
| SCHEMBL6833560 | 0.74 | MCL1 (0.74) | POLBKDM4EHSD17B10KMT2AALDH1A1 | |
| SCHEMBL8706801 | 0.74 | MCL1 (1.00) | POLBKDM4EHSD17B10KMT2AALDH1A1 | |
| SCHEMBL15836637 | 0.74 | KMT2A (1.00) | POLBKDM4EHSD17B10KMT2AALDH1A1 | |
| SCHEMBL15836702 | 0.74 | KMT2A (0.79) | TDP1POLBKDM4EHSD17B10KMT2A | |
| SCHEMBL24589796 | 0.74 | KMT2A (0.66) | TDP1POLBKDM4EHSD17B10KMT2A | |
| SCHEMBL8706946 | 0.72 | MCL1 (0.72) | TDP1POLBKDM4EHSD17B10KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8026285-B2 | Control release of biologically active compounds from multi-armed oligomers | BEZWADA BIOMEDICAL, LLC (US) | 2011-09-27 | — | — | US | claimed |
| US-20090076174-A1 | CONTROL RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS FROM MULTI-ARMED OLIGOMERS | BEZWADA BIOMEDICAL, LLC (US) | 2009-03-19 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-3356440-B1 | HYDROPHOBIC HIGHLY BRANCHED CARBOHYDRATE POLYMERS | PURDUE RESEARCH FOUNDATION (US) | 2024-06-05 | — | — | EP | disclosed |
| US-20220257770-A1 | HYDROPHOBIC HIGHLY BRANCHED CARBOHYDRATE POLYMERS | PURDUE RESEARCH FOUNDATION (US) | 2022-08-18 | — | — | US | disclosed |
| US-11052153-B2 | Highly branched alpha-D-glucans | PURDUE RESEARCH FOUNDATION (US) | 2021-07-06 | — | — | US | disclosed |
| US-20200268894-A1 | HYDROPHOBIC HIGHLY BRANCHED CARBOHYDRATE POLYMERS | PURDUE RESEARCH FOUNDATION (US) | 2020-08-27 | — | — | US | disclosed |
| US-10689330-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2020-06-23 | — | — | US | disclosed |
| US-20200165192-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2020-05-28 | — | — | US | disclosed |
| US-10653784-B2 | Hydrophobic highly branched carbohydrate polymers | PURDUE RESEARCH FOUNDATION (US) | 2020-05-19 | — | — | US | disclosed |
| US-6261537-B1 | TARGETS AND ULTRASOUND DIAGNOSIS OF ACTIVE MATERIALS, AQUEOUS CARRIER LIQUIDS, CARRIERS AND FILM FORMING SURFACTANT PHOSPHATIDES | NYCOMED IMAGING AS (NO) | 2001-07-17 | — | — | US | disclosed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | disclosed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | disclosed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | disclosed |
| EP-0878549-A2 | Process for the enzymatic production of fructosylated compounds | Chemisches Laboratorium Dr. Kurt Richter GmbH (DE) | 1998-11-18 | — | — | EP | disclosed |
| WO-1993016064-A1 | COUMARIN DERIVATIVES AND THEIR ANALOGUES INHIBITING CELL PROLIFERATION AND TUMOUR GROWTH, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME | BIOSIGNAL, Kutató-Fejleszto^' Kft. (HU) | 1993-08-19 | — | — | WO | disclosed |
| US-4705779-A | Pharmaceutical compositions of anti-pancreatic inflammatory effect | BIOGAL GYOGYSZERGYAR OF DEBRECEN AND ALKALOIDA VEGYESZETI GYAR OF TISZAVASVARI (HU) | 1987-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10653784-B2 | Hydrophobic highly branched carbohydrate polymers | HACD3, ALG1, HACD2 | TDP1 4255/4885POLB 3423/4885KDM4E 4796/4885 |
| US-20090076174-A1 | CONTROL RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS FROM MULTI-ARMED OLIGOMERS | MME, CTSA, ALG1 | TDP1 971/4885POLB 1563/4885KDM4E 3828/4885 |
| US-20200268894-A1 | HYDROPHOBIC HIGHLY BRANCHED CARBOHYDRATE POLYMERS | HACD3, ALG1, HACD2 | TDP1 4255/4885POLB 3423/4885KDM4E 4796/4885 |
| US-10689330-B2 | Amino acid derivatives and absorbable polymers therefrom | SRRM2, SLC7A1, BCAT2 | TDP1 1961/4885POLB 4422/4885KDM4E 2679/4885 |
| US-20200165192-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | TDP1 1961/4885POLB 4422/4885KDM4E 2679/4885 |
| US-20220257770-A1 | HYDROPHOBIC HIGHLY BRANCHED CARBOHYDRATE POLYMERS | HACD3, ALG1, HACD2 | TDP1 4255/4885POLB 3423/4885KDM4E 4796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.